RBC Life Sciences, Inc. Announces MPM Medical Expansion into Latin America

IRVING, Texas--(BUSINESS WIRE)--RBC Life Sciences, Inc. (OTCBB: RBCL) today announced that its wholly owned subsidiary, MPM Medical, Inc., has entered into a 15-year exclusive distributorship agreement with Glenmark, Farmaceutica LTDA, a pharmaceutical distributor located in Sao Do Campo – SP, Brazil. Through this distribution agreement Glenmark retains exclusive marketing and distribution rights in Brazil for two of MPM’s unique wound care products, which are used by oncology patients suffering from adverse reactions to certain oncology treatments.

Back to news